All contributors
Onconephrology contributor
Jhaveri, Kenar D
Primarily Onco-nephrology (general)#17 of 47 recognizedHonor roll
- #1 in Onco-nephrology (general)
53
Clinical papers
1,641
Citations (iCite)
5 / 19
First / senior author
2011–2026
Active years
Output over time
Clinical corpus papers per year — peak 9 in 2022.
- 2011: 1 paper
- 2015: 2 papers
- 2016: 3 papers
- 2017: 3 papers
- 2018: 2 papers
- 2019: 1 paper
- 2020: 3 papers
- 2021: 8 papers
- 2022: 9 papers
- 2023: 5 papers
- 2024: 5 papers
- 2025: 3 papers
- 2026: 8 papers
20112026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Onco-nephrology (general)32
Anticancer drug nephrotoxicity19
Myeloma cast nephropathy11
MGRS & paraprotein kidney disease7
Cellular therapy renal effects6
Anti-VEGF / TKI renal effects4
Tumor lysis & electrolytes3
Checkpoint-inhibitor kidney injury3
Frequent collaborators
Other recognized contributors who most often share corpus papers with Jhaveri (shared-paper count).
Agents they study
Catalog agents whose clinical kidney literature lists Jhaveri among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.